Eighteen genes that propel a common and aggressive form of brain cancer in adults have been identified, says a study.
The study, carried out by researchers at the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, was published Monday in Nature Genetics.
"Cancers rely on driver genes to remain cancers, and driver genes are the best targets for therapy," said Antonio Iavarone, professor of pathology and neurology at Columbia University Medical Center and a principal author of the study.
"Once you know the driver in a particular tumour and you hit it, the cancer collapses. We think our study has identified the vast majority of drivers in glioblastoma and, therefore, a list of the most important targets for glioblastoma drug development and the basis for personalized treatment of brain cancer."
Personalized treatment could be a reality soon for about 15 percent of glioblastoma patients, said Anna Lasorella, associate professor of paediatrics and of pathology & cell biology at CUMC, reports Science Daily.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
